已收盤 08-07 16:00:00 美东时间
-1.960
-2.99%
华盛资讯8月8日讯,Skyward Specialty Insurance Group, Inc.公布2026财年Q2业绩,公司Q2营收4.90亿美元,同比增长53.0%,归母净利润0.49亿美元,同比增长26.3%。
08-08 05:20
今日重点评级关注:HC Wainwright & Co.:维持Precigen"买入"评级,目标价从14美元升至18美元;HC Wainwright & Co.:维持Sophia Genetics"买入"评级,目标价从12美元升至14美元
08-06 11:36
Barclays analyst Alex Scott maintains Skyward Specialty (NASDAQ:SKWD) with a Overweight and raises the price target from $65 to $68.
08-05 21:18
华盛资讯8月5日讯,Skyward Specialty Insurance Group, Inc.公布2026财年Q2业绩,公司Q2营收4.59亿美元,同比增长54.0%,归母净利润0.49亿美元,同比增长25.6%。
08-05 04:32
今日重点评级关注:Needham:维持Annexon"买入"评级,目标价从11美元升至25美元;Benchmark:维持Prenetics Global"买入"评级,目标价从30美元升至40美元
07-16 18:55
Piper Sandler analyst Paul Newsome maintains Skyward Specialty (NASDAQ:SKWD) with a Overweight and raises the price target from $68 to $72.
07-15 19:37
今日重点评级关注:摩根士丹利:维持TeraWulf"超配"评级,目标价从66.5美元升至72美元;HC Wainwright & Co.:维持Vera Therapeutics"买入"评级,目标价从110美元升至125美元
07-09 12:35
今日重点评级关注:Canaccord Genuity:维持AtaiBeckley"买入"评级,目标价从15美元升至17美元;Truist Securities:维持NUVATION BIO"买入"评级,目标价从12美元升至13美元
07-08 15:31
Piper Sandler analyst Paul Newsome maintains Skyward Specialty (NASDAQ:SKWD) with a Overweight and raises the price target from $55 to $68.
07-07 19:33
As of June 29, 2026, three stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go...
06-29 20:58